-
Aytu BioScience Receives $5M Investment To Further Expansion Plans, Enter 'Cough And Cold' Market
Monday, November 5, 2018 - 2:00pm | 335Read More...Micro-cap pharmaceutical company Aytu BioScience, Inc. (NASDAQ: AYTU) is responsible for global commercialization of products to treat low testosterone, insomnia and male infertility. What Happened On Monday, Aytu BioScience revealed its entry into the $3 billion cough and cold market, through...
-
Thursday's Hedge Fund Moves: A Look At Small & Micro-Caps
Friday, July 3, 2015 - 9:36am | 297Read More...Many investors consider tracking hedge fund moves central to their strategy. So, let’s take a look at Thursday’s most relevant transactions involving small-cap companies. The largest company featured in this article is a $2 billion market cap specialty chemicals manufacturer: Olin...
-
Can Pep Boys Deliver Earnings Growth This Quarter? Experts & Crowd Disagree
Monday, June 8, 2015 - 12:49pm | 292Read More...Pep Boys-Manny Moe and Jack (NYSE: PBY) is set to announce its first quarter financial results after Monday's close. According to Estimize, the Street anticipates flat year-over-year earnings of $0.03 per share on marginally higher revenue of $549.8 million – compared to $538.8 million...
-
Spectrum Pharmaceuticals Up 10% On Activist's Letter
Tuesday, May 12, 2015 - 3:46pm | 309Read More...Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) gained 10 percent Tuesday after an activist said the company could fetch more than $7.95 a share in a sale. The company focused on hematology and oncology changed hands recently at $6.68, up $0.62 (10.2 percent). Armistice Capital disclosed a 5.4...
